BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12397640)

  • 1. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region.
    Kanazawa T; Watanabe T; Kazama S; Tada T; Koketsu S; Nagawa H
    Int J Cancer; 2002 Nov; 102(3):225-9. PubMed ID: 12397640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability: a study matched for T classification and tumor location.
    Kazama Y; Watanabe T; Kanazawa T; Tada T; Tanaka J; Nagawa H
    Cancer; 2005 May; 103(10):2023-9. PubMed ID: 15812832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: a study matched for T classification and tumor location.
    Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
    J Surg Oncol; 2008 Mar; 97(3):278-83. PubMed ID: 18161865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
    Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
    Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional allelic loss in gastric carcinoma correlates with growth patterns.
    Choi SW; Park SW; Lee KY; Kim KM; Chung YJ; Rhyu MG
    Oncogene; 1998 Nov; 17(20):2655-9. PubMed ID: 9840929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.
    Nishizuka S; Tamura G; Terashima M; Satodate R
    J Pathol; 1998 May; 185(1):38-43. PubMed ID: 9713358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of colorectal cancers in young patients based on chromosomal loss and microsatellite instability.
    Tada T; Watanabe T; Kanazawa T; Kazama S; Koketsu S; Nagawa H
    Scand J Gastroenterol; 2004 Nov; 39(11):1134-40. PubMed ID: 15545173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
    Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
    Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
    Matsumura T; Makino R; Mitamura K
    Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
    Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
    Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
    Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
    Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
    Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the loss of heterozygosity at the APC/MCC and DCC genetic loci in colorectal cancers].
    Lui Y; Fang D; Lu R
    Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):439-43. PubMed ID: 9592312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
    Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
    J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
    Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
    J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.
    Arnold CN; Goel A; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
    Cancer Biol Ther; 2004 Oct; 3(10):960-4. PubMed ID: 15326380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
    Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
    Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.